References
- Bam NB, Cleland JL, Yang J, et al. Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci 1998;87:1554–1559
- Lee HJ, Mcauley A, Schilke KF, McGuire J. Molecular origins of surfactant-mediated stabilization of protein drugs. Adv Drug Deliv Rev 2011;63:1160–1171
- Kerwin BA. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. J Pharm Sci 2008;97:2924–2935
- Jang SA, Lee DS, Lee MW, Woo SH. Toxicity of phenanthrene dissolved in nonionic surfactant solutions to Pseudomonas putida P2. FEMS Microbiol Lett 2007;267:194–199
- Adamo M, Dick Jr LW, Qiu D, et al. A simple reversed phase high-performance liquid chromatography method for polysorbate 80 quantitation in monoclonal antibody drug products. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:1865–1870
- Tani TH, Moore JM, Patapoff TW. Single step method for the accurate concentration determination of polysorbate 80. J Chromatogr A 1997;786:99–106
- Wuelfing WP, Kosuda K, Templeton AC, et al. Polysorbate 80 UV/Vis spectral and chromatographic characteristics-defining boundary conditions for use of the surfactant in dissolution analysis. J Pharm Biomed Anal 2006;41:774–782
- Baker SD, Zhao M, He P, et al. Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry. Anal Biochem 2004;324:276–284
- Cardamone M, Puri NK. Spectrofluorimetric assessment of the surface hydrophobicity of proteins. Biochem J 1992;282:589–593
- Shrivastava A, Gupta VB. Methods for the determination of limit of detection and limit of quantitation of the analysis methods. Chron Young Sci 2011;2:21–25